论文部分内容阅读
作者过去7年采用化疗+小剂量放疗和放疗+化疗两种方案对40例小细胞肺癌进行了治疗。其中男性34例,女性6例,平均年龄为67(49～86)岁。局限型(LD)19例,广泛型(ED)21例。化疗患者34例(85%)。其中,COMP+小剂量放疗(COMPrt)24例(69%),ACNU+VCR(ACNU)8例(23%),METVFC2例(6%)。为增加COMPrt(Cyclophosphamide,Onco vin Methotrexate,Procarbazine)联合化疗的效果,化疗前4小时先行100 rad放疗。作为合并疗法,对14例(35%)进行了放疗,3例(7.5%)进行了手术治疗,余6例单独放疗4例
In the past 7 years, the authors treated 40 cases of small cell lung cancer with chemotherapy + low-dose radiotherapy and radiotherapy + chemotherapy. There were 34 males and 6 females with an average age of 67 (49-86) years. There were 19 cases of localized type (LD) and 21 cases of extensive type (ED). Thirty-four patients (85%) were treated with chemotherapy. Among them, COMP+ (COMPrt) was 24 cases (69%), ACNU+VCR (ACNU) was 8 cases (23%), and METVFC was 2 cases (6%). In order to increase the efficacy of COMPrt (Cyclophosphamide, Onco vin Methotrexate, Procarbazine) combined chemotherapy, 100 rad radiotherapy was given 4 hours before chemotherapy. As a combination therapy, radiotherapy was performed in 14 cases (35%), surgical treatment was performed in 3 cases (7.5%), and 4 cases were radiotherapy alone in the remaining 6 cases.